Confluence Investment Management’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
Other funds holding RMD
TIA
WF
VF
AT
AS
TIM
Confluence Investment Management's RMD Position: Q2 2026 in Review
Confluence Investment Management reduced its ResMed (RMD) stake by 5.8% in Q2 2026, selling an estimated $1.19M and leaving 94,086 shares worth $18.3M. The position accounts for 0.29% of the portfolio, ranked #87.
Confluence Investment Management first reported a position in RMD in Q1 2024 and has held it in 10 quarters since. The position peaked at $31M in Q3 2024. 319 funds tracked by Wall St. Rank hold RMD as of Q2 2026.
- Confluence Investment Management held 94,086 shares of ResMed worth $18.3M as of Q2 2026.
- Confluence Investment Management sold 5,759 ResMed shares in Q2 2026, an estimated $1.19M.
- ResMed made up 0.29% of Confluence Investment Management's portfolio in Q2 2026, its #87 holding.
- Confluence Investment Management first reported a position in ResMed in Q1 2024 and has held it in 10 quarters since.
- Confluence Investment Management's ResMed position peaked at $31M in Q3 2024.
- 319 funds tracked by Wall St. Rank held ResMed as of Q2 2026.
Based on Confluence Investment Management's 13F filing for Q2 2026, filed 1 Jul 2026.